NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the Piper Jaffray Nineteenth Annual Healthcare Conference in New York, NY on Tuesday, November 27, 2007 at 1:00 p.m. EST. A corporate overview will be provided, including additional information on the Company’s product portfolio.
